ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Plasmapheresis"

  • 2022 American Transplant Congress

    Treatment Modality and Outcomes of Antibody-Mediated Rejection in Pediatric Kidney Transplant Recipients: The PARAMOUr Study

    R. Engen1, A. Jain2, N. Hayde3, A. Mansuri4, M. Kallash5, S. McEwen6, R. Garro7, C. Peterson8, R. Zahr9, L. Harshman10, D. Puliyanda11, S. Solomon12, K. Twombley13, I. Ashoor14

    1Pediatrics, University of Wisconsin Madison, Madison, WI, 2Wayne State University, Detroit, MI, 3Albert Einstein College of Medicine, New York, NY, 4Augusta University, Augusta, GA, 5The Ohio State University, Columbus, OH, 6University of Minnesota, Minneapolis, MN, 7Emory University, Atlanta, GA, 8University of Utah Health, Salt Lake City, UT, 9The University of Tennessee Health Science Center, Memphis, TN, 10University of Iowa, Iowa City, IA, 11Cedars-Sinai Medical Center, Los Angeles, CA, 12New York Medical College, Valhalla, NY, 13Medical University of South Carolina, Charleston, SC, 14Louisiana State University, New Orleans, LA

    *Purpose: Antibody-mediated rejection (AMR) is the leading cause of graft failure in kidney transplantation, but evidence for effective treatments is limited.*Methods: PARAMOUr is a retrospective…
  • 2022 American Transplant Congress

    Two Times or More Double-Filtration Plasmapheresis Increases the Risk of Bleeding During Kidney Transplantation

    T. Kanzawa, T. Tagisawa, M. Furusawa, K. Unagami, K. Kitajima, K. Omoto, H. Ishida, K. Tanabe, T. Takagi

    Urology, Tokyo Women's Medical University, Tokyo, Japan

    *Purpose: Double-filtration plasmapheresis (DFPP) is effective for desensitization in ABO incompatible and highly sensitized transplantation. In such cases, bleeding is difficult to stop due to…
  • 2022 American Transplant Congress

    Excellent Long-Term Outcome of ABO-Incompatible Living Kidney Transplantation by Reduced-Session of Plasmapheresis of Desensitization Protocol

    Y. Ishiyama1, K. Tanabe2, T. Kanzawa2, K. Unagami2, H. Ishida2, T. Takagi2

    1Urology, Tokyo Women's Medical University Medical Center East, Arakawa, Japan, 2Tokyo Women's Medical University, Tokyo, Japan

    *Purpose: Plasmapheresis (PE) is applied to ABO-incompatible living kidney transplantation (ABOi-LKT) in order to remove ABO blood type antibody to obtain the appropriate target levels.…
  • 2022 American Transplant Congress

    Outcomes of Post-Operative Plasmapheresis in African American Kidney Transplant Recipients with High Panel Reactive Antibodies – A Single Center Experience

    B. Valdepenas, M. Campara, J. Benken, C. Muran, D. Pierce, K. Heagler, P. DiCocco, J. Almario Alvarez, M. Spaggiari, I. Tang, I. Tzvetanov, E. Benedetti

    University of Illinois at Chicago, Chicago, IL

    *Purpose: African American (AA) kidney transplant (KTx) candidates are disadvantaged given increased immunologic risk and longer waitlist time. The purpose of this study was to…
  • 2022 American Transplant Congress

    Impact of the High Baseline Anti-a/b Antibody Titer on the Clinical Outcomes in ABO-incompatible Living Donor Liver Transplantation

    J. Cho, B. Lee, H. Lee

    Surgery, Seoul National Bundang Hospital, Seongnam, Korea, Republic of

    *Purpose: Recently, advances in desensitization protocol have made ABO-incompatible (ABOi) living donor liver transplantation (LDLT) feasible option in the era of organ shortage. Although, multiple…
  • 2022 American Transplant Congress

    Plasmapheresis Dependent AT1R Antibody Associated Recurrent FSGS After Living Donor Kidney Transplantation

    R. K. Mallavarapu

    Transplant Nephrology, Augusta University - Medical College of Georgia, Augusta, GA

    *Purpose: Antibodies against Angiotensin II type 1 receptors (AT1R-Abs) may predispose to podocyte injury, glomerular endotheliosis and proteinuria. The management of AT1R-Ab associated recurrent FSGS…
  • 2021 American Transplant Congress

    Guiding Therapeutic Plasma Exchange for Amr Treatment in Lung Transplant Recipients Using Serial Dilution in Single Antigen Bead Assay

    O. A. Timofeeva1, J. Choe2, M. Alsammak2, E. J. Yoon2, S. Geier2, K. Carney2, J. Au2, A. Diamond2, J. A. Galli2, K. Shenoy2, A. Mamary2, S. Seghal2, P. Mullhal2, Y. Toyoda2, N. Shigemura2, F. Cordova2, G. Criner2, J. Brown2

    1MedStar Georgetown University Hospital, Washington, DC, 2Temple University Hospital, Philadelphia, PA

    *Purpose: Development of donor‐specific antibodies (DSA) is associated with poor outcomes in lung transplantation. Patients who are presented with at least probable AMR require treatment;…
  • 2021 American Transplant Congress

    A Comparison of Plasmapheresis Methods in the Treatment of Late Antibody Mediated Rejection

    Y. Caliskan1, H. Yazici2, A. B. Dirim2, E. Aksoy2, S. Safak2, N. Garayeva2, S. Mirioglu2, O. Yegit2, O. A. Oto2, Y. Ozluk3, S. Besisik4, A. Turkmen2, K. Lentine1

    1Saint Louis University, Saint Louis, MO, 2Division of Nephrology, Istanbul University, Istanbul, Turkey, 3Department of Pathology, Istanbul University, Istanbul, Turkey, 4Division of Hematology, Istanbul University, Istanbul, Turkey

    *Purpose: Effective management to prevent allograft loss after late antibody mediated rejection (ABMR) in kidney transplant (KTx) recipients remains a vexing clinical challenge. While plasma…
  • 2021 American Transplant Congress

    Weathering the Cytokine Storm: Therapeutic Plasma Exchange for the Management of Severe Covid19 in Solid Organ Transplant Recipients

    A. Mattiazzi1, J. Pagan1, L. A. Mendez Castaner2, A. Fernandez1, R. Zamora Gonzalez1, J. Simkins1, L. Preczewski1, Y. Natori1, S. Anjan1, G. Guerra1

    1Miami Transplant Institute, Miami, FL, 2Miami Trasnplant Institute, Miami, FL

    *Purpose: The treatment of SARS-CoV-2 associated pneumonia in solid organ transplant recipients (SOTr) continues to be under investigation. Timely control of the cytokine release storm…
  • 2021 American Transplant Congress

    Outcomes of Kidney Transplant Recipients with Antibody-mediated Allograft Rejection: A Retrospective Study

    A. Al Jurdi1, L. Goldfarb1, M. Lafargue2, J. Azzi3, L. V. Riella1

    1Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, 2Université de Paris, Paris, France, 3Transplantation Research Center, Brigham and Women’s Hospital, Boston, MA

    *Purpose: The optimal regimen for treating acute and chronic antibody-mediated rejection (AMR) in kidney transplant recipients has yet to be established. The purpose of the…
  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences